Compositional Analysis of Glycosaminoglycans in Different Lung Cancer Types—A Pilot Study
Authors:
- Domonkos PálDPDomonkos Pál
- Gábor TóthGTGábor Tóth
- Simon SugárSimon Sugár
- Kata Dorina FügediKFKata Dorina Fügedi
- Dániel SzabóDSDániel Szabó
- Ilona KovalszkyIlona Kovalszky
- Dávid PappDPDávid Papp
- Gitta SchlosserGSGitta Schlosser
- Csaba TóthCTCsaba Tóth
- Tamás TornóczkyTTTamás Tornóczky
- László DrahosLászló Drahos
- Lilla TuriákLTLilla Turiák
Open Access
- 11 April 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (8) , 7050
Abstract
Lung cancer is one of the most commonly diagnosed cancer types. Studying the molecular changes that occur in lung cancer is important to understand tumor formation and identify new therapeutic targets and early markers of the disease to decrease mortality. Glycosaminoglycan chains play important roles in various signaling events in the tumor microenvironment. Therefore, we have determined the quantity and sulfation characteristics of chondroitin sulfate and heparan sulfate in formalin-fixed paraffin-embedded human lung tissue samples belonging to different lung cancer types as well as tumor adjacent normal areas. Glycosaminoglycan disaccharide analysis was performed using HPLC-MS following on-surface lyase digestion. Significant changes were identified predominantly in the case of chondroitin sulfate; for example, the total amount was higher in tumor tissue compared to the adjacent normal tissue. We also observed differences in the degree of sulfation and relative proportions of individual chondroitin sulfate disaccharides between lung cancer types and adjacent normal tissue. Furthermore, the differences in the 6-O-/4-O-sulfation ratio of chondroitin sulfate were different between the lung cancer types. Our pilot study revealed that further investigation of the role of chondroitin sulfate chains and enzymes involved in their biosynthesis is an important aspect of lung cancer research.Keywords
Funding Information
- National Research, Development, and Innovation Fund of Hungary (2018-1.2.1-NKP-2018-00005, FK 131603, SNN 138407)
- Hungarian Academy of Sciences (2018-1.2.1-NKP-2018-00005, FK 131603, SNN 138407)
- Hungarian Ministry for Innovation and Technology (2018-1.2.1-NKP-2018-00005, FK 131603, SNN 138407)
This publication has 39 references indexed in Scilit:
- Workflow for Combined Proteomics and Glycomics Profiling from Histological TissuesAnalytical Chemistry, 2014
- New Pathologic Classification of Lung Cancer: Relevance for Clinical Practice and Clinical TrialsJournal of Clinical Oncology, 2013
- Heparan Sulfate BiosynthesisJournal of Histochemistry & Cytochemistry, 2012
- An Introduction to Proteoglycans and Their LocalizationJournal of Histochemistry & Cytochemistry, 2012
- O-GlcNAcylation is a novel regulator of lung and colon cancer malignancyBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Disaccharide structure code for the easy representation of constituent oligosaccharides from glycosaminoglycansNature Methods, 2008
- Turning Sweet on CancerScience, 2003
- Pathology of lung cancerClinics in Chest Medicine, 2002
- Altered glycosaminoglycan composition in reactive and neoplastic human liverBiochemical and Biophysical Research Communications, 1990
- Aberrant Glycosylation In Tumors And Tumor-Associated Carbohydrate Antigens1989